MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA Lifts Warning Letter on Guidant

After reinspecting Guidant's cardiac rhythm management site in St. Paul, FDA has lifted a warning letter on the company. Now a division of Boston Scientific, Guidant received the warning in December 2005 when FDA inspectors found quality control problems at the site. The letter also came following a series of defibrillator recalls by the company. Boston Scientific's quality system improvements paid off, as FDA's reinspection of the facility last year reported no problems. The company is still not in the clear though.

It received a warning letter in January 2006 regarding its drug-coated stents. The Boston Globe reports that it doesn't expect that letter to be resolved until the second half of 2007.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.